Ostalo

Melanomas in renal transplant recipients: a single-centre study

Tajana Borlinić ; General Hospital Čakovec
Tamara Knežević ; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb
Lana Gellineo ; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb
Maja Franceschi ; Department of Nuclear Medicine, University Hospital Sisters of Mercy Zagreb School of Medicine University of Osijek
Zrinka Bukvić Mokos ; Department of Dermatology and Venerology, University Hospital Centre Zagreb School of Medicine University of Zagreb
Nikolina Bašić-Jukić ; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb School of Medicine University of Zagreb School of Medicine University of Osijek

Sažetak

Skin cancers are the most common malignancies in renal transplantrecipients, with squamous-cell and basal-cell cancers accounting for the majorityof all skin cancer cases. Melanoma is relatively rare in this group of patients.From 1973 to May 2017, out of 1889 patients who received allografts at our institution,4 developed melanoma. After the mean follow-up of 11.5 months, 2patients died and 2 are still alive with functioning allografts. Malignancies werelocalized in the legs in both female patients, and in the neck and head in 1 malepatient each. Compared to the general population of Croatia, renal transplantrecipients from our cohort have 6.85 times higher risk for development of melanoma.Regular screenings and patient education are mandatory, especially inMediterranean countries.

Ključne riječi

skin cancer; melanoma; renal transplantation; immunosuppression; outcome

Hrčak ID:

192897

URI

https://hrcak.srce.hr/192897

Datum izdavanja:

20.1.2018.

Posjeta: 639 *